Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Intubation Pressor Response
NCT06592027Phase 4Completed
- Sponsor
- Theodor Bilharz Research Institute
- Start
- Feb 2024
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in pressor response (2 arms), sponsored by Theodor Bilharz Research Institute. Primary endpoint: Heart rate measurement. Started Feb 2024; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
pressor response
Beyond the preview
Go deeper on NCT06592027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06592027.